Products Applications & Insights Knowledge & Support About QIAGEN My QIAGEN Quick Order Cart Site Search Investor Relations NYSE: QGEN FRA: QIA 56.47+1.91 (3.50%) Pricing delayed by 20 minutes. Last Updated 26/11/2021 at 4:00 PM ET Overview At a glance Stock Information Financial Reports & SEC Filings Corporate Governance Compliance & Sustainability Events & Presentations IR Contacts Investor Relations Overview Why Invest Strong balance sheet LEARN MORE Sustainable diversified growth LEARN MORE Well positioned in attractive global markets LEARN MORE Latest News VIEW ALL NEWS November 26, 2021 QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529 READ MORE November 9, 2021 QIAGEN launches StableScript reverse transcriptase as an OEM product READ MORE November 8, 2021 QIAGEN commits to reduce carbon emissions by setting science-based target to reach net zero by 2050 READ MORE November 5, 2021 QIAGEN and BD settle patent infringement lawsuit READ MORE Q3 2021 Latest Quarterly Results Press Release (opens in new window) Webcast (opens in new window) Presentation (opens in new window) Transcript (opens in new window) SEC Filing (opens in new window) VIEW ALL QUARTERLY RESULTS View our Deep Dive content to learn more about our strategy Presentations Videos Our Five Pillars of Growth QIAGEN Virtual Deep Dive Presentations Download (opens in new window) PDF, 3.53 MB VIEW THE FULL DEEP DIVE EVENT LIBRARY Events & Presentations November 29, 2021Conferences & Roadshows Virtual SGCIB Conference Add to Calendar November 30, 2021Conferences & Roadshows Virtual ISI Healthcare Conference Add to Calendar Webcast (opens in new window) VIEW ALL EVENTS & PRESENTATIONS IR Contacts John Gilardi Vice President Head of Corporate Communications and Investor Relations Germany +49 2103 29 11711 U.S. +1 240 686 2222 The Netherlands +31 773 55 66 66 john.gilardi@qiagen.com Download VCARD Phoebe Loh Senior Director Investor Relations +49 2103 29 11457 phoebe.loh@qiagen.com Download VCARD Alexandra Koenig Investor Relations Coordinator +49 2103 29 11709 alexandra.koenig@qiagen.com Download VCARD Email Alerts Email Address SIGN UP Press Releases Events Presentations SEC-Filings End of Day Stock Quote Unsubscribe Follow Us linkedin open in new window facebook open in new window twitter open in new window youtube open in new window linkedin open in new window Contact Us call back mail BACK TO TOP This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Sample to Insight © QIAGEN 2013-21. All rights reserved Privacy Policy Trademarks & Disclaimers Accessibility Powered By Q4 Inc. 5.56.0.1 (opens in new window)